Printer Friendly

INAMED REPORTS RECORD SECOND QUARTER AND SIX MONTH PROFITS

 LAS VEGAS, Aug. 16 /PRNewswire/ -- INAMED Corporation (NASDAQ: IMDC; PSE: INA), headquartered in Las Vegas, today reported record net income of $1,823,716, or $.23 per share, on sales of $21,258,780 for the second quarter ended June 30, 1993, as compared to net income of $1,241,374, or $.15 per share, on sales of $21,435,315 in the like year-ago quarter.
 For the first six months of 1993, the company reported net income of $3,338,486, or $.42 per share, on sales of $42,603,490. This compares to net income of $2,248,748, or $.27 per share, on sales of $38,167,221 in the first half of last year.
 According to INAMED chairman Donald K. McGhan, reduced competition in the mammary implant area has enabled the company to maintain strong sales performance with growing profitability in both domestic and international markets. The company's manufacturing plant in Ireland now supplies the majority of product to the international market, and "We are now considering expansion of this facility," said Mr. McGhan.
 Mr. McGhan said that management has intensified its focus on the development of INAMED's non-implant businesses. "We are encouraged by early results from clinical studies now being conducted on newly developed products for the bariatric market. One of the most promising of these products is the gastric band for the treatment of obesity.
 "We remain cautiously optimistic about the future growth of the company. Unresolved claims related to breast implants have increased significantly from prior years, and the outcome of pending litigation cannot be predicted. We expect legal costs to be a continued draw on liquidity for the foreseeable future."
 INAMED Corporation is a medical and surgical device company with 15 operating subsidiaries in the U.S. and Europe. The company develops, manufactures and markets medical devices for the plastic and reconstructive, bariatric and general surgery markets. It also designs and manufactures key silicone components for use in products marketed by other major U.S. medical device companies.
 The company reported sales of over $64.3 million for calendar/fiscal 1992.
 INAMED CORPORATION
 Earnings Recap
 Period Ended Three months Six months
 June 30, 1993 1992 1993 1992
 Net sales $21,258,780 $21,435,315 $42,603,490 $38,167,221
 Net income 1,823,716 1,241,374 3,338,486 2,248,748
 Profit per share $.23 $.15 $.42 $.27
 Weighted average
 shares outstng. 7,916,650 8,202,453 7,917,029 8,202,453
 -0- 8/16/93
 /CONTACT: Michael D. Farney, CEO, 702-791-3388, or Jimmy Caplan, 805-569-0076, both of INAMED/
 (IMDC)


CO: INAMED Corporation ST: Nevada IN: MTC SU:

MP -- NYM015 -- 2920 08/16/93 09:15 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Aug 16, 1993
Words:451
Previous Article:GREG MANNING AUCTIONS ENTERS INTO BUSINESS ARRANGEMENT WITH HARMER ROOKE GALLERIES
Next Article:STANDARD & POOR'S STOCK PRICE INDEX OPENING, MONDAY, AUG. 16 /PRN/
Topics:

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters